Fredun Pharmaceuticals consolidated net profit rises 96.92% in the September 2026 quarter

Sales rise 85.15% to Rs 265.85 crore

Net profit of Fredun Pharmaceuticals rose 96.92% to Rs 18.57 crore in the quarter ended September 2026 as against Rs 9.43 crore during the previous quarter ended September 2025. Sales rose 85.15% to Rs 265.85 crore in the quarter ended September 2026 as against Rs 143.59 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	265.85	143.59	85
OPM %	15.93	15.55	-
PBDT	33.58	14.60	130
PBT	29.65	12.71	133
NP	18.57	9.43	97

Powered by Capital Market - Live News